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Abstract. 
 
Addition of brefeldin A (BFA) to mamma-
lian cells rapidly results in the removal of coatomer 
from membranes and subsequent delivery of Golgi en-
zymes to the endoplasmic reticulum (ER). Microin-
jected anti-EAGE (intact IgG or Fab-fragments), anti-
bodies against the “EAGE”-peptide of
 
 b
 
-COP, inhibit 
BFA-induced redistribution of 
 
b
 
-COP in vivo and 
block transfer of resident proteins of the Golgi complex 
to the ER; tubulo-vesicular clusters accumulate and 
Golgi membrane proteins concentrate in cytoplasmic 
patches containing 
 
b
 
-COP. These patches are devoid of 
marker proteins of the ER, the intermediate compart-
ment (IC), and do not contain KDEL receptor. Inter-
estingly, relocation of KDEL receptor to the IC, where 
it colocalizes with ERGIC53 and ts-O45-G, is not inhib-
ited under these conditions. While no stacked Golgi cis-
ternae remain in these injected cells, reassembly of 
stacks of Golgi cisternae following BFA wash-out is in-
 
hibited to only 
 
z
 
50%. Mono- or divalent anti-EAGE 
stabilize binding of coatomer to membranes in vitro, at 
least as efficiently as GTP
 
g
 
S. Taken together these re-
sults suggest that enhanced binding of coatomer to 
membranes completely inhibits the BFA-induced ret-
rograde transport of Golgi resident proteins to the ER, 
probably by inhibiting fusion of Golgi with ER mem-
branes, but does not interfere with the disassembly of 
the stacked Golgi cisternae and recycling of KDEL re-
ceptor to the IC. These results confirm our previous re-
sults suggesting that COPI is involved in anterograde 
membrane transport from the ER/IC to the Golgi com-
plex (Pepperkok et al., 1993), and corroborate that 
COPI regulates retrograde membrane transport be-
tween the Golgi complex and ER in mammalian cells.
 
V
 
ectorial
 
 protein and membrane transport in the
secretory pathway is mediated by vesicular carriers.
Despite the enormous membrane traffic through
this pathway, each compartment maintains a unique and
defined membrane composition; in addition a balance be-
tween forward membrane transport and recycling must be
kept. Two basic mechanisms operating in the regulation of
this membrane flow are sorting and recycling. Coat pro-
teins (COPs)
 
1
 
 have been implicated in sorting of cargo
into coated buds and formation of vesicular transport in-
termediates (Robinson, 1994; Rothman, 1994; Kreis et al.,
1995; Schekman and Orci, 1996): COPII at the ER (Bar-
lowe et al., 1994; Aridor et al., 1995), COPI at the ER/IC
(Pepperkok et al., 1993; Griffiths et al., 1995) and Golgi
complex (Malhotra et al., 1989), clathrin and AP1 (Robin-
son, 1994), as well as so far poorly characterized COPs at
the 
 
trans
 
-Golgi network (TGN) the exit site of the Golgi
complex (Griffiths et al., 1985; Ladinsky et al., 1994;
Narula and Stow, 1995). Immunolocalization of COPs in
mammalian cells is consistent with their sites of action
(Oprins et al., 1993; Griffiths et al., 1995; Shaywitz et al.,
1995). In yeast COPI and COPII appear both involved in
the formation of distinct anterogradely directed transport
intermediates from ER membranes (Bednarek et al.,
1995). Missorted ER proteins and components of the tar-
geting and fusion machinery bearing specific signals are
retrieved from the IC and the Golgi complex by specific
receptors, like the KDEL receptor for example (Pelham,
1995; see also Miesenbock and Rothman, 1995), and ge-
netic evidence in yeast indicates that retrograde transport
of proteins with an ER retrieval signal KKXX depends on
COPI (Letourneur et al., 1994; Cosson et al., 1996; see
 
however also Duden et al., 1994; Wuestehube et al., 1996)
 
. 
 
The organization of membrane traffic in tissue culture
cells is disrupted by BFA. BFA interferes with the func-
tion of a membrane bound GTP exchange factor and thus
prevents association of ARFs, small GTPases (Boman and
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1.
 
 Abbreviations used in this paper
 
: BFA, brefeldin A; COP, coat protein;
EM, electron microscopy; endo H, endoglycosidase H;
 
 
 
IC, intermediate
compartment. 
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Kahn, 1995), with membranes (Donaldson et al., 1992; Helms
and Rothman, 1992; Stamnes and Rothman, 1993). As a
consequence, binding of COPI (and most likely some other
related COPs), as well as the TGN, but not the cell sur-
face, clathrin adaptors, to membranes is inhibited (Don-
aldson et al., 1990; Robinson and Kreis, 1992). The final
result is a dramatic reorganization of endocellular mem-
branes; membranes of compartments connected in the
secretory and endocytic pathways appear to fuse with one
another in a nonregulated manner and sorting of cargo is
impaired (Hunziker et al., 1991; Lippincott-Schwartz et al.,
1991; Orci et al., 1991; Wood et al., 1991)
 
.
 
 Most signifi-
cantly, membranes of the Golgi complex relocate into the
ER leading to the rapid disappearance of morphologically
distinct stacks of Golgi cisternae (Misumi et al., 1986; Oda
et al., 1987; Lippincott-Schwartz et al., 1989; see also Ul-
mer and Palade, 1991). This BFA induced relocation has
given valuable insights into components and mechanisms
that might be involved in the regulation of transport in the
early secretory pathway (Klausner et al., 1992). Yet, it re-
mains to be shown how closely BFA-induced relocation of
Golgi components into the ER resembles the normal ret-
rograde pathway(s) involved in recycling material from
the Golgi complex to the IC/ER, and the role of coatomer
in these processes is not yet fully understood (Pelham, 1991).
The BFA-induced transfer of Golgi components to the ER
may be due to uncovering a fusion machinery following
dissociation of coatomer (Orci et al., 1991). This process
could then lead to a nonregulated fusion of related mem-
branes that normally do not fuse, a consequence of uncou-
pling the sequential events of budding, uncoating, and fu-
sion of transport intermediates (Elazar et al., 1994; Rothman
and Warren, 1994). Alternatively, and not mutually exclu-
sive, exposure of receptors for microtubule-based molecu-
lar motors may induce the movement of 
 
cis
 
-Golgi mem-
branes to sites adjacent to ER membranes and somehow
facilitate their fusion (Pelham, 1991; Lippincott-Schwartz
et al., 1995). 
Microinjection of antibodies into living cells has proven
a powerful alternative approach to studies with cell-free
systems and genetic analyses in yeast for characterizing
functions of COPs in membrane traffic in mammalian cells
in vivo. In this study we have used specific polyclonal anti-
bodies raised against peptides of 
 
b
 
-COP, a subunit of
coatomer (Duden et al., 1991), for further characterizing
the role of COPI in membrane traffic between the ER/IC
and Golgi complex. Microinjected antibodies against the
EAGE peptide inhibit transport of newly synthesized tem-
perature sensitive membrane glycoprotein of vesicular sto-
matitis virus (ts-O45-G) between the ER/IC and the Golgi
complex (Pepperkok et al., 1993). We show here that these
antibodies also interfere with the BFA-induced transport
of Golgi proteins into the ER. Biochemical and morpho-
logical analyses of these inhibitory effects suggest that
anti-EAGE interfere with dissociation of coatomer from
membranes leading to the inhibition of the subsequent fu-
sion of membranes of the Golgi complex with those of the
ER. The inhibitory effects of anti-EAGE on anterograde
transport from the IC to the Golgi complex and on BFA-
induced retrograde transport appear to be different, sug-
gesting that the function of COPI may be regulated differ-
ently in these two pathways.
 
Materials and Methods
 
Cell Culture, Microinjection, and Microscopy
 
Vero cells (African green monkey kidney cells, Amer. Type Culture Col-
lection, Rockville, MD; CCL81) were maintained and infected with tsO45-
VSV (Indiana serotype) as described earlier (Kreis and Lodish, 1986). Micro-
injection was performed on a computer automated microinjection system
(AIS, Zeiss, Zürich, Switzerland) as described (Pepperkok et al., 1993). Vero
cells stably expressing myc-tagged NAGT1 were obtained from Dr. Brian
Storrie (Blacksburg). Immunofluorescence was performed as described
(Pepperkok et al., 1993) with antibodies against calnexin (Hammond and
Helenius, 1994), PDI (Vaux et al., 1990), ERGIC53 (Schweizer et al.,
1988), KDEL receptor (Tang et al., 1995), p58 (Bloom and Brashear,
1989), 
 
b
 
-COP (Pepperkok et al., 1993), 
 
b9
 
-COP (Lowe and Kreis, 1995),
and VSV-G (Kreis, 1986). The Golgi complex was visualized in Vero cells
expressing myc-tagged NAGT1 with a monoclonal antibody against the
myc-epitope (Evan et al., 1985) as described (Pierre et al., 1994). 
Images of immunolabeled cells were recorded on a Zeiss inverted fluo-
rescence microscope (Axiovert TV135) equipped with a cooled CCD
camera (Photometrics CH250, 1317X1035 pixels, Tucson, AZ), controlled
by a Power Macintosh 8100/100 and the software package IPLab spectrum
V2.7 (Signals Analytics Corp., Vienna, VA). Images were further pro-
cessed using Adobe Photoshop V3.0 before printing with a Xanté laser
press 1800 (Conware Informatik AG, Baar, Switzerland). 
Quantitative electron microscopy (EM) on microinjected cells was per-
formed as described (Pepperkok et al., 1993), and the volume density of
Golgi membranes per cell determined by point counting
 
 
 
(Weibel, 1979).
 
Metabolic Labeling and Biochemical Analyses of 
Maturation of ts-O45-G
 
500–1,000 cells, grown on a glass coverslip (Pepperkok et al., 1993), were
infected with tsO45-VSV and incubated for 1.5 h in culture medium fol-
lowed by 10 min incubation in labeling medium (culture medium lacking
methionine and cysteine). Cells were metabolically labeled with 2.8 mCi
[
 
35
 
S]methionine (Amersham Corp., Arlington Heights, IL) per ml labeling
medium for 20 min. Cells were washed and placed into low carbonate cul-
ture medium containing 100 
 
m
 
g/ml cycloheximide for microinjection (all
incubations up to this step and the microinjection were done at 39.5
 
8
 
C).
Cells were further chased (in culture medium containing 100 
 
m
 
g/ml cyclo-
heximide) as indicated in the figure legends. Preparation of cell lysates,
immunoprecipitation of ts-O45-G, endoglycosidase H (endo H) digestion,
gel electrophoresis, and fluorography were performed as described (Pep-
perkok et al., 1993). 
 
Preparation of Rat Liver Cytosol and Enriched
IC/Golgi Membranes 
 
To prepare rat liver cytosol 30 g of frozen rat liver was thawed at 4
 
8
 
C,
minced in 60 ml of homogenization buffer (20 mM Hepes-KOH [pH 7.0],
100 mM KCl, 2.5 mM MgCl
 
2
 
, 1 mM PMSF, 0.5 mM 1:10 phenanthroline,
2 mM pepstatin A, 2 mg/ml aprotinin, 0.5 
 
m
 
g/ml leupeptin) and homoge-
nized with a Polytron using three 30-s bursts on setting 4. The resulting
homogenate was centrifuged at 12,000 
 
g
 
 for 15 min in a 18.50 rotor (Her-
aeus SA, Carouge-Genève, Switzerland). The supernatant was collected
and centrifuged at 100,000 
 
g
 
 for 1 h in a TST 41.14 rotor (Koutron Instru-
ments, Schlieren, Switzerland). The resulting supernatant was collected
and centrifuged for a further 2 h at 200,000 
 
g
 
 in the TST 41.14 rotor. The
200,000-
 
g
 
 supernatant (rat liver cytosol) was frozen in liquid nitrogen and
stored at 
 
2
 
80
 
8
 
C. Golgi/IC enriched membranes were prepared from rat
liver using the method of Malhotra et al. (1989).
 
Quantifying Binding of Coatomer to
Membranes In Vitro
 
Incubations (120 
 
m
 
l total volume) were carried out for 10 min at 37
 
8
 
C in
the presence of 14 
 
m
 
g Golgi/IC membranes, 25 mM Hepes-KOH (pH 7.0),
25 mM KCl, 2.5 mM MgCl
 
2
 
, 50 
 
m
 
M ATP, 2 mM creatine phosphate, 12.5
U/ml creatine kinase, and 160
 
 
 
m
 
g rat liver cytosol. Further additions were
made as indicated in the figure legends. Reactions were layered on top of
200 
 
m
 
l of 15% sucrose (in 25 mM Hepes-KOH [pH 7.0], 25 mM KCl) and
centrifuged at 4
 
8
 
C in a microcentrifuge for 30 min at 15,000 rpm. The su-
pernatants were discarded and the membrane pellets resuspended in 15 
 
m
 
l
SDS sample buffer. Proteins were separated by SDS-PAGE and trans- 
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ferred to nitrocellulose for immunoblotting. 
 
b
 
-
 
COP was detected using
the monoclonal antibody M3A5 (Allan and Kreis, 1986) at a 1:1,000 dilu-
tion followed by horseradish peroxidase–conjugated goat anti–mouse IgG
(Cappel, Malvern, PA) at a 1:2,000 dilution. Peroxidase labeling was de-
tected using the ECL kit (Amersham) and quantified by densitometry.
 
Results
 
Microinjection of Anti-EAGE Inhibits BFA-induced 
Transfer of Golgi Enzymes to the ER
 
Anti-EAGE, when microinjected into cells, inhibit antero-
grade transport of ts-O45-G from the ER/IC to the Golgi
complex (Pepperkok et al., 1993). These antibodies may
directly inhibit this transport by interfering with the for-
mation or function of transport vesicles, or the inhibition
may be indirect by preventing recycling of essential factors
for anterograde transport. In an attempt to further clarify
this issue we analyzed the effect of injected anti-EAGE on
the putative recycling of Golgi enzymes between the Golgi
complex and the ER/IC, and on BFA-induced relocation
of Golgi proteins to the ER/IC. If continuous recycling of
Golgi enzymes through the ER/IC normally occurred, one
should expect an accumulation of these enzymes in the
ER/IC when anterograde transport between the ER/IC and
Golgi complex is selectively blocked. As a consequence,
Golgi specific trimming of the viral glycoprotein accumu-
lated in the ER/IC should be detected.
To analyze a possible recycling of Golgi enzymes through
the ER/IC, Vero cells were infected with tsO45-VSV and
kept at nonpermissive temperature (39.5
 
8
 
C, predomi-
nantly ER accumulation), or 15
 
8
 
C (IC accumulation). Un-
der these conditions, ts-O45-G arrested in the ER or IC
may serve as a substrate for oligosaccharide-processing
Golgi enzymes, and transport of these enzymes into the
ER/IC can be studied by biochemical analyses of modifi-
cations of the oligosaccharide side chains of the viral gly-
coprotein
 
 
 
(Doms et al., 1989)
 
. 
 
Even after accumulation of
ts-O45-G in the ER or IC for up to 6 h no trace of endo
H-resistant glycoprotein could be detected in cells injected
with anti-EAGE at the respective temperature (as in non-
injected control cells; Fig. 1 
 
A
 
). Moreover, when cells were
injected with anti-EAGE at 39.5
 
8
 
C and kept for three ad-
ditional hours at the nonpermissive temperature and then
for 3 h at 15
 
8
 
C with ts-O45-G finally accumulated in the IC
(anti-EAGE does not inhibit ER to IC transport) no endo
H-resistant fraction of the viral glycoprotein could be de-
tected (not shown). Thus, either the recycling of (even a
small fraction of) Golgi enzymes through the ER/IC is
inhibited by the injected antibodies, or these enzymes,
once located at their proper site of function within the
Golgi complex, are retained. To investigate directly the
role of coatomer in transport from the Golgi complex to
the ER/IC in vivo, we used BFA-induced transfer of Golgi
enzymes into the ER combined with microinjection of spe-
cific antibodies raised against synthetic peptides of 
 
b
 
-COP
(anti-EAGE and anti-110-12; Pepperkok et al., 1993) and
 
b9
 
-COP (Lowe and Kreis, 1995).
Under normal conditions, ts-O45-G is not modified by
Golgi enzymes at 39.5
 
8
 
C and therefore remains sensitive
to digestion with endo H for at least 6 h (Fig. 1 
 
A
 
, 
 
n.i. 6h
 
).
Treatment of cells with BFA relocates Golgi enzymes to
the ER within 15–30 min (Domes et al., 1989; Lippincott-
Schwartz et al., 1989) and renders ER accumulated ts-O45-G
endo H resistant at 39.5
 
8
 
C (Fig. 1 
 
B
 
, 
 
n.i. 2.5h
 
). However,
ts-O45-G remains completely endo H sensitive at this
temperature in cells, microinjected with anti-EAGE or its
Fab-fragments, which have subsequently been treated
with BFA (Fig. 1 
 
B
 
, 
 
EAGE
 
). Thus, microinjection of anti-
EAGE blocks the transfer of Golgi enzymes to the ER
where ts-O45-G is accumulated. This inhibition is specific
for anti-EAGE, since microinjected anti-110-12 have no
effect on BFA induced acquisition of endo H resistance of
ts-O45-G (Fig. 1 
 
B
 
, 
 
110-12
 
). 
 
Distribution of Golgi, IC, and ER Proteins in
BFA-treated Cells Microinjected with Antibodies 
against 
 
b
 
-COP
 
In control noninjected cells ts-O45-G accumulates in the
ER at 39.5
 
8
 
C and colocalizes with PDI or calnexin (data not
Figure 1. Biochemical analysis of transfer of Golgi enzymes to
the ER. Transfer of Golgi enzymes to the ER was determined
biochemically by analyzing acquisition of endo H resistance of ts-
O45-G arrested in the ER. 500–1000 Vero cells infected with
tsO45-VSV were incubated for 1.5 h at 39.58C, metabolically la-
beled for 10 min with 35S-met and microinjected at 39.58C or 158C
with Fab-fragments of anti-EAGE (EAGE), divalent anti–110-12
(110-12), or kept as noninjected controls (n.i.). (A) Noninjected
control cells were lysed directly after the pulse with 35S-met and
ts-O45-G analyzed for endo H sensitivity (0 h). 39.58C: control or
injected cells were lysed and ts-O45-G analyzed for endo H sensi-
tivity after a chase of 6 h at 39.58C; 158C: temperature was shifted
for 2 h to 158C before injection at 158C, and the cells were kept
for an additional 4 h at 158C before lysis and analysis of endo H
resistance of ts-O45-G. (B) Control and injected cells were
chased for 0 h or 2.5 h at 39.58C in the presence of 5 mg/ml BFA
before lysis and analysis of endo H resistance of ts-O45-G. Micro-
injected anti-EAGE, but not anti-110-12 block BFA induced ac-
quisition of endo H resistance of ts-O45-G. 
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shown). Microinjection of anti-EAGE has no effect on the
localization of ts-O45-G in the ER at nonpermissive tem-
perature (e.g., Fig. 3, 
 
a
 
 and 
 
b
 
). The lack of BFA-induced
acquisition of endo H resistance of ts-O45-G in these cells
must therefore be due to inhibition of delivery of Golgi
enzymes to the ER. To analyze this transport block mor-
phologically, we colocalized microinjected antibodies and
several marker proteins for the ER, IC, and Golgi com-
plex by immunofluorescence microscopy.
The resident Golgi membrane proteins NAGT I (Fig. 2 
 
e
 
)
and Man II (not shown), as well as p58, a protein associ-
ated with the cytoplasmic surface of Golgi membranes
(Bloom and Brashear, 1989), accumulate in 
 
b
 
-COP posi-
tive patches (Fig. 2 
 
f
 
) when virus-infected cells, microin-
Figure 2. Effect of microinjected anti-EAGE on BFA induced relocation of Golgi enzymes. Vero cells were microinjected with Fab-
fragments of anti-EAGE. 30 min after injection 5 mg/ml BFA was added to the medium and cells were incubated for further 2.5 h at
378C. Cells were then fixed and double stained for injected antibodies (b, d, and f) and marker proteins for (a) the ER (PDI), (c) the in-
termediate compartment (ERGIC 53), and (e) the Golgi complex (NAGT1). Microinjected antibodies accumulate in patches (arrow-
heads in d; arrows in f) which colocalize with NAGT1 (arrows in e) but not ERGIC 53 and PDI. The injected anti-EAGE thus affect the
BFA-induced relocalization of Golgi proteins to the ER. Bar, 10 mm. 
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jected with anti-EAGE, are treated with BFA while con-
tinuously kept at 39.5
 
8
 
C. These patches do not contain the
“IC marker lectin” ERGIC53 (Schweizer et al., 1988; Schin-
dler et al., 1993; Arar et al., 1995; Fig. 2, 
 
c
 
 and d), and the
ER marker proteins, PDI and calnexin (not shown), main-
tain their reticular distributions and are not enriched in
these structures either (Fig. 2, a and b). Furthermore, no
ts-O45-G accumulates in these patches under nonpermis-
sive conditions (Fig. 3, c and d). Interestingly, the normally
predominantly  cis-Golgi localized KDEL receptor accu-
mulates in these BFA-treated cells in the patches contain-
ing ts-O45-G (Fig. 4, d and e) and ERGIC53, and not in
those positive for Golgi enzymes or injected anti-EAGE
(Fig. 4 c). This result indicates that injected anti-EAGE
does not interfere with the BFA-induced relocation of
KDEL receptor to the IC. Furthermore, the distribution
of KDEL receptor (Fig. 4 a) appears not significantly
changed in control cells microinjected with anti-EAGE
(Fig. 4 b); occasionally, formation of tubular structures can
be observed. The formation of these aggregates is specific
for injected anti-EAGE, since neither microinjected anti-
110-12 nor anti–b9-COP (not shown; these antibodies when
injected into cells bind to coatomer in vivo) lead to an ac-
cumulation of coat proteins in patches under these condi-
tions (Fig. 3, e and f), and no significant number of the
b-COP and Golgi protein containing aggregates form in
the absence of BFA at nonpermissive temperature (Fig. 3,
a and b). Furthermore, the effect of injected anti-EAGE is
not dominant over the effect of BFA, since if the antibod-
ies were injected after BFA treatment of infected cells, no
patches could be seen (not shown). It is also an early effect
of BFA action, since patches containing Golgi proteins
and b-COP can already be observed z5 min after addi-
tion of the drug (data not shown). These results corrobo-
rate our biochemical data which suggest that ts-O45-G does
not meet Golgi enzymes in BFA-treated cells which have
Figure 3. Effect of microinjected
anti-EAGE and BFA on the distribu-
tion of ts-O45-G. ts-O45 VSV-infected
Vero cells, kept for 2 h at 39.58C,
were microinjected at nonpermissive
temperature with Fab-fragments of
anti-EAGE (a–d) or with anti-110-12
(e and f). After injection control cells
were incubated for further 6 h at
39.58C (a and b), or for 2.5 h at 39.58C
with 5 mg/ml BFA (c–f). Cells were
then fixed and labeled for injected
antibodies (b, d, and f) and ts-O45-G
(a, c, and e). Injected anti-EAGE has
no effect on ts-O45-G in the ER in
the control cells kept at 39.58C (a and
b). BFA treatment, however, in-
duces accumulation of ts-O45-G in
cytosolic patches (arrows in c and e)
which are distinct from the patches
where anti-EAGE accumulate (ar-
rowheads in d). Anti-110-12 main-
tains its diffuse cytosolic distribution
after BFA treatment (f). Bar, 15 mm.The Journal of Cell Biology, Volume 137, 1997 324
been injected with anti-EAGE. Thus, injected anti-EAGE
inhibits the BFA-induced transfer of resident Golgi proteins
to the ER and leads to a rapid accumulation of Golgi pro-
teins in COPI containing cytoplasmic aggregates distinct
from the ER/IC. 
Interestingly, upon addition of BFA to noninjected virus-
infected control cells kept at nonpermissive temperature, a
significant fraction of ts-O45-G also accumulates in patchy
structures (Fig. 5; see also Fig. 3, c and e). These patches
show no enhanced staining with antibodies against PDI or
calnexin (not shown) which retain their typical ER distri-
bution (Fig. 5 b). However, they are enriched in ERGIC53
(Fig. 5 d), p58 (Fig. 5 h), and contain b-COP (Fig. 5 f).
These patches are usually not observed in noninfected
cells. These results suggest that in these BFA-treated cells
newly synthesized membrane proteins destined to the cell
surface, as well as Golgi proteins and proteins recycling
between the ER/IC and the Golgi complex, either accu-
mulate in a subdomain of the ER which probably corre-
sponds to the IC (see also Hammond and Helenius, 1994),
or are transported in a BFA/COPI independent way from
the ER to the IC.
Quantitative EM analysis of thin sections revealed that
virtually no identifiable Golgi stacks remained after a 1-h
treatment with BFA at 39.58C in control (anti-110-12) or
anti–EAGE-injected cells (Fig. 6 a). Thus, the scattered
patches of Golgi membranes positive for b-COP seen by
immunofluorescence microscopy in cells injected with anti-
EAGE and after BFA treatment are unlikely to represent
Golgi mini-stacks. In contrast, numerous dense spherical
aggregates (Fig. 7 c) were found in the BFA-treated cells
microinjected with anti-EAGE but not anti-110-12 (Fig. 6 c).
The number of these spherical aggregates appears to corre-
spond roughly with the number of b-COP–positive patches
expected from light microscopy observations. Similar struc-
tures shown to contain b-COP and membranes have previ-
ously been observed in different cell types under various
conditions of treatment (Oprins et al., 1993; Orci et al.,
1993; Pepperkok et al., 1993; Hendricks et al., 1993). Fur-
thermore, a significant fraction of tubulo-vesicular struc-
tures (Fig. 7, a, d, and e) appear in the injected cells; al-
though more of these clusters are found in cells injected
with anti-EAGE, a significant number is also present in
control injected cells (Fig. 6 b). Thus, it is possible that in
cells injected with anti-EAGE, BFA-induced relocation of
resident Golgi proteins is arrested in these spherical aggre-
gates. Since the tubulo-vesicular clusters are present in cells
injected with either antibodies, they probably represent
the structures where ts-O45-G, ERGIC53, and Golgi
markers accumulate in BFA-treated cells, i.e., the IC. 
Figure 4. Effect of microinjected
anti-EAGE on BFA induced relo-
cation of KDEL receptor. ts-O45-
VSV–infected Vero cells were mi-
croinjected at 39.58C with Fab-frag-
ments of anti-EAGE (asterisks). 30
min after injection, cells were trans-
ferred into medium containing 5
mg/ml BFA (c–e) or kept in normal
medium (a and b). Cells were fixed
after 2 h and double labeled with a
murine monoclonal antibody recog-
nizing KDEL receptor (a) and rab-
bit anti-EAGE (b), or triple labeled
for injected anti-EAGE (c), KDEL
receptor (d), and ts-O45-G (e).
Anti-KDEL receptor was visual-
ized with cy3-labeled antibodies
against mouse IgG and anti-EAGE
Fab-fragments with fluorescein an-
tibodies against rabbit IgG. Cells
were then incubated with 5 mg/ml
mouse IgG, after this first incuba-
tion with secondary antibodies, to
saturate free binding sites for
mouse IgG on cy3-anti–mouse. Fi-
nally, ts-O45-G was labeled with
cy5-conjugated P5D4. Arrows indi-
cate aggregates containing anti-
EAGE; note that these patches do
not  contain KDEL receptor or
ts-O45-G. Arrowheads indicate
patches  containing KDEL receptor
and ts-O45-G note that these
patches do not contain anti-
EAGE. Bar, 10 mm. Scheel et al. Anti-EAGE Inhibits BFA-induced Fusion of Golgi with ER Membranes 325
Microinjected Anti-EAGE Inhibits Reformation
of Golgi Stacks after BFA Wash-Out
Anti-EAGE inhibit protein transport in the anterograde
(Pepperkok et al., 1993), as well as in the BFA-induced
retrograde (this report) direction in vivo. While mixing of
Golgi and ER membranes is induced by BFA, sorting of
Golgi- from ER-specific components and subsequent trans-
fer of these components to the location where the new
Golgi complex will reassemble must occur upon removal
of the drug. These processes may depend on the machin-
ery regulating anterograde transport or reflect an intrinsic
property of Golgi specific components to self assemble. If
Figure 5. Effect of BFA on
the distribution of ER, IC,
and Golgi complex-associated
proteins in VSV-infected cells.
ts-O45 VSV-infected Vero
cells were incubated with 5
mg/ml BFA for 2.5 h at 39.58C
and then fixed and double
stained for ts-O45-G (a, c, e,
and g) and the ER protein
PDI (b), the IC marker pro-
tein ERGIC 53 (d), b-COP
(f), and Golgi membrane as-
sociated p58 (h). ts-O45-G
accumulates in patches en-
riched in ERGIC53, b-COP,
and p58; PDI maintains its
typical ER distribution and is
not affected by BFA. Bar,
10  mm.The Journal of Cell Biology, Volume 137, 1997 326
coatomer is essential for anterograde membrane traffic,
and Golgi reformation after wash-out of BFA followed
that pathway, then microinjected anti-EAGE should in-
hibit Golgi reassembly.
Virus-infected Vero cells were treated with BFA for 1 h,
microinjected with antibodies in the presence of BFA at
39.58C, and subsequently transferred to medium at per-
missive temperature lacking the drug. Initially, ts-O45-G is
accumulated in ERGIC53 positive patches (Fig. 8, a and b).
In uninjected cells or cells injected with anti-110-12, ts-
O45-G is transported normally to the plasma membrane
through the reforming Golgi apparatus (data not shown).
However, in cells microinjected with anti-EAGE, ts-O45-G
is arrested in tubular structures (Fig. 8 c) positive for
ERGIC53 (Fig. 8 d), suggesting that under these condi-
tions anterograde protein transport is blocked in the IC,
apparently in identical fashion to injected cells shifted to
permissive temperature that had not been treated with BFA
(Pepperkok et al., 1993). Similarly to the anti–EAGE–
injected cells not treated with BFA, b-COP accumulates in
patches which were often found on or at the ends of tu-
bules containing ERGIC53 and ts-O45-G (Fig. 8, e and f).
Interestingly, NAGT1 (myc-tagged and stably expressed
in Vero cells) and p58 (not shown) resumed an apparently
normal Golgi distribution in about half of the cells injected
with anti-EAGE within 1 h after removal of BFA (Fig. 9, c
and d); in the other cells, NAGT1 remained in perinuclear
clusters (e.g., lower injected cell in Fig. 9 c). No significant
effect on Golgi reassembly was found in cells injected with
anti-110-12 (Fig. 9, a and b). It appears that coatomer does
not accumulate in a vesicular pattern at the periphery of
the Golgi complex demarcated by a medial-Golgi resident
protein (NAGT1) in cells injected with anti-EAGE (Fig. 9,
c and d), as is typically observed in control cells or cells in-
jected with anti-110-12 (see arrows in Fig. 9, a, b, e, and f). 
Golgi complex reassembly during BFA wash-out was
further studied by quantitative EM on thin sections of mi-
croinjected cells and determination of the volume density
of Golgi membranes was performed. Golgi stacks were ab-
sent in BFA-treated cells before the wash-out of the drug
(not shown). In uninjected control cells or cells injected
with anti-110-12, Golgi stacks reappear rapidly after wash-
out of BFA (Fig. 6 a). The percent cell volume of reformed
Golgi stacks was however inhibited by z50% in cells micro-
injected with anti-EAGE (Fig. 6 a) and in contrast to the
control cells, many of the BFA-induced tubulo-vesicular
clusters remained (Fig. 6 b). No dense spherical aggregates
have, however, been detected in cells injected with either
of the two antibodies after BFA wash-out (Fig. 6 c). We
thus conclude that reassembly of the Golgi complex is only
partly inhibited by the injected anti-EAGE. Interestingly,
biochemical analyses also revealed only z50% inhibition
of acquisition of endo H resistance of ts-O45-G, although
virtually no viral glycoprotein reaches the cell surface un-
der these conditions (Pepperkok et al., 1993).
Anti-EAGE Stabilizes Membrane Binding of b-COP
Relocation of coatomer is a rapid and early event of BFA
action (Donaldson et al., 1990). In cells injected with anti-
EAGE, however, b-COP remains associated with patches
containing Golgi membrane proteins for at least 2 h after
addition of the drug (Fig. 3, e and f). This is an effect spe-
cific for microinjected anti-EAGE. Analyses of early time
points (1–20 min) after addition of the drug to cells micro-
injected with these antibodies gave no evidence for an in-
termittent dissociation of b-COP from membranes, indi-
cating that b-COP remains associated with the membranes
Figure 6. Quantitative EM analysis of the effect of injected anti-
bodies against b-COP on the BFA-induced reorganization of the
Golgi complex. ts-O45 VSV-infected (2 h) Vero cells were micro-
injected with antibodies against b-COP before or after treatment
with 5 mg/ml BFA for 1 h. Thin sections of these cells were ana-
lyzed by EM and the volume density of Golgi stacks, tubulo-
vesicular clusters, and dense spherical aggregates determined
(Weibel, 1979) in at least 10 different fields (see Fig. 6 for exam-
ples of these structures). Injected antibodies have no effect on the
disappearance of distinct Golgi stacks. Injected Fab-fragments of
anti-EAGE, but not anti-110-12, inhibit, however, the reassembly
of Golgi stacks by z50% after BFA wash-out for 1 h and numer-
ous tubulo-vesicular clusters remain which are abundant after
treatment of cells with BFA. Also, electron dense spherical ag-
gregates form in anti–EAGE-injected BFA-treated cells, and
they readily disappear upon removal of the drug. Error bars rep-
resent the standard mean error.
Figure 7. Morphological EM analysis of the effect of injected antibodies against b-COP on the BFA-induced reorganization of the
Golgi complex. Typical examples for the structures identified and quantified in Fig. 5 in BFA-treated ts-O45 VSV-infected cells injected
with Fab-fragments of anti-EAGE (a–c and f) or with anti-110-12 (d, e, and g) are shown. Cells in a–e have been treated for 1 h with 5
mg/ml BFA 30 min after injection with antibodies, while BFA has been washed-out for 1 h from cells shown in f and g. a shows a low mag-
nification and b a higher magnification micrograph of tubulo-vesicular clusters that typically accumulate in BFA-treated cells injected with
anti-EAGE; electron dense spherical aggregates are illustrated in c. In d and e tubulo-vesicular clusters are shown at low and high mag-
nification in control cells injected with anti-110-12. Reassembled stacks of Golgi cisternae are shown in cells injected with anti-EAGE (f)
or anti-110-12 (g). C, cisterna; CE, centriole pair; G, stacks of Golgi cisternae; N, nucleus; RER, rough ER; asterisks in a and d indicate
tubulo-vesicular clusters, and in c, dense spherical aggregates. Arrowheads indicate possible COP-coated buds or vesicles. Bars: (b, c,
and e) 100 nm; (a, d, f, and g) 200 nm.Scheel et al. Anti-EAGE Inhibits BFA-induced Fusion of Golgi with ER Membranes 327The Journal of Cell Biology, Volume 137, 1997 328
during their redistribution into patches. Thus anti-EAGE
appears to inhibit the dissociation of coatomer from mem-
branes in vivo. Since interference with the dynamics of mem-
brane interactions of b-COP could be the mechanism by
which anti-EAGE affects membrane traffic, we character-
ized the membrane binding of b-COP in a cell-free system.
A small fraction of b-COP remains associated in vitro
with membranes enriched in Golgi and IC after incubation
with rat liver cytosol (Fig. 10). This binding is significantly
increased (up to threefold) in the presence of GTPgS, in
agreement with previous reports (Donaldson et al., 1991).
A 2–3-fold enhanced binding of coatomer to Golgi mem-
branes, similar to the levels obtained with GTPgS, can also
be observed in the presence of anti-EAGE (Fig. 10). This
increased binding occurs also with monovalent Fab-frag-
ments, can be completely competed by pre-incubation of
anti-EAGE with the EAGE peptide, and is specific since
it does not occur with control antibodies anti-110-12 (Fig.
10). Thus, anti-EAGE significantly increases the fraction
of membrane-bound coatomer. These results and the block
of BFA’s activity to remove b-COP from membranes in
living cells microinjected with anti-EAGE suggest that
anti-EAGE interferes with the regulation of dissociation
of b-COP from membranes, most likely by locking it to-
gether with the other subunits of coatomer, in its mem-
brane-bound form. We assume that this inhibition of
membrane dissociation of coatomer by anti-EAGE inter-
feres with membrane traffic between the ER/IC and the
Golgi complex.
Discussion
We microinjected specific antibodies against b-COP to
further dissect the role of coatomer in membrane traffic in
living mammalian cells. We show here that microinjected
antibodies directed against the EAGE-peptide of b-COP
block BFA-induced transfer of resident Golgi enzymes to
the ER, presumably by inhibiting the fusion of Golgi with
ER membranes. Interestingly, relocation of KDEL recep-
tor, a membrane protein cycling between the cis-Golgi and
the IC, is not affected in these cells. Together with our pre-
vious results, which show inhibition of anterograde protein
transport from the ER/IC to the Golgi complex by the
same antibodies (Pepperkok et al., 1993), these results in-
Figure 8. Effect of microinjected anti-
EAGE on transport of ts-O45-G fol-
lowing BFA wash-out. ts-O45 VSV-
infected Vero cells were treated for 1 h
at 39.58C with 5 mg/ml BFA. These
cells were then microinjected at non-
permissive temperature with Fab-frag-
ments of anti-EAGE and coumarin
conjugated BSA as an injection indica-
tor. Cells were incubated for further 30
min at 39.58C in the presence of BFA af-
ter microinjection and then fixed (a and
b) or incubated in medium without
BFA for one more hour at 318C to
wash-out the drug before fixation (c–f).
Cells were immunolabeled for ERGIC
53 (b and d), ts-O45-G (a, c, and e), or
injected anti-EAGE (f). Injected cells
were identified in a–d by the co-injected
coumarine BSA (not shown). ts-O45-G
is arrested in tubular structures colo-
calizing with ERGIC 53 (arrowheads
in c–e). Arrows in e and f indicate
ts-O45-G positive dots which are la-
beled with the injected antibodies
against  b-COP. Bar, 10 mm.Scheel et al. Anti-EAGE Inhibits BFA-induced Fusion of Golgi with ER Membranes 329
dicate that COPI is involved in the regulation of both an-
terograde (IC to Golgi) and retrograde (Golgi to ER)
membrane traffic in the early exocytic pathway.
Anti-EAGE stabilizes in vitro binding of coatomer to
membranes at least as efficiently as GTPgS, and in vivo, a
significant fraction of coatomer remains bound to aggre-
gates of membranes in cells treated with BFA. Out of two
dozen antibodies raised against peptides along the se-
quence of b-COP only two (anti-EAGE, anti-110-12) bound
to coatomer when injected into cells and only anti-EAGE
interferes with coatomer function (Pepperkok et al., 1993).
The other epitopes must thus be buried inside a protein fold,
or are inaccessible within the stable hetero-oligomeric
protein complex. Indeed, upon reversible disassembly of
coatomer into its monomeric subunits these “hidden”
epitopes of b-COP become accessible to the respective pep-
tide antibodies (Lowe and Kreis, 1995). Thus, the domain
around the EAGE-epitope appears to be a major site for
heterologous liaisons involved in regulating membrane
binding of coatomer. Anti-EAGE may either mask the
site where a factor binds b-COP that regulates dissociation
of coatomer from its membrane receptor(s), or interfere
with a conformational change of b-COP essential for dis-
sociation of coatomer from membranes. While strong evi-
dence suggests that a subcomplex of coatomer composed
of a-, b9-, and e-COP binds to membrane proteins with an
Figure 9. Effect of injected antibodies against b-COP on the localization of NAGT1 after BFA wash-out in VSV-infected cells. ts-O45
VSV-infected Vero cells were incubated for 1 h at 39.58C with 5 mg/ml BFA and subsequently microinjected at 39.58C with Fab-frag-
ments of anti-EAGE or with anti-110-12 in the presence of BFA. Cells were transferred into normal medium immediately after injec-
tion and BFA washed-out at 318C for 1 h. Cells were then fixed and stained for injected antibodies (b and d) and NAGT1 (a and c). Control
cells were double labeled for NAGT1 (e) and b-COP (f) for comparison. In many cells anti-EAGE interfere with the proper reassembly
of a compact Golgi complex in a juxtanuclear region (e.g., lower injected cells in d). Injected anti-EAGE also appears to interfere with the
distribution of coatomer; b-COP and NAGT1 are more tightly colocalized in these injected cells (c and d) than in cells injected with anti-
110-12 or in control cells where b-COP is “wrapped-around” the NAGT1 positive membranes (arrows in a, b, e, and f). Bar, 10 mm.The Journal of Cell Biology, Volume 137, 1997 330
ER-retrieval motif (Cosson and Letourneur, 1994; Lowe
and Kreis, 1995), and that another coatomer subcomplex
(containing z- and g-COP) may interact with members of
the p24 membrane proteins with a putative “phenylalanine”
anterograde transport motif (Fiedler et al., 1996; Harter
et al., 1996), our data indicate that b-COP must be inti-
mately involved in the regulation of membrane binding of
the coatomer complex. Interestingly, binding of the a-, b9-,
and e-COP subcomplex to membranes in vitro is insensi-
tive to GTPgS (Lowe and Kreis, 1995). It is possible that
b-COP, perhaps together with d-COP with which it inter-
acts directly in the complex (Lowe and Kreis, 1995), may
be involved in conferring ARF-dependent, GTP sensitiv-
ity to coatomer–membrane interaction.
In normal cells at steady state, membrane-bound coatomer
visualized with antibodies against b-COP is on vesicular
structures scattered throughout the cytoplasm or closely
attached to, and surrounding, the Golgi complex (Duden
et al., 1991; Kreis et al., 1995). Interestingly, while about
half of the b-COP coated vesicular structures that can be
identified immediately upon shifting tsO45-VSV–infected
cells to the permissive temperature (after accumulation of
ts-O45-G in the IC at 158C) colocalize with ts-O45-G, the
other half appears not to contain viral glycoprotein and
may thus be recycling vesicles (Griffiths et al., 1995). This
observation is consistent with the hypothesis that
coatomer is involved in both anterograde and retrograde
membrane transport. When injected anti-EAGE interfere
with transport from the IC to the Golgi complex, cargo
(e.g., ts-O45-G) is found in tubular structures containing
ERGIC53 and b-COP (Pepperkok et al., 1993). However,
when anti-EAGE interferes with BFA induced relocation
of resident Golgi membrane proteins to the ER, virtually
no overlap of b-COP with ERGIC-53 and KDEL receptor
is observed, yet coatomer closely colocalizes with “Golgi-
derived cargo.” In both situations no obvious vesicular
structures accumulate, but numerous aggregates can be
seen with which b-COP is associated (see also Pepperkok
et al., 1993; Oprins et al., 1993). Since these aggregates are
significantly more abundant in injected, BFA-treated cells
and contain Golgi resident membrane proteins, but not re-
cycling KDEL receptor, ERGIC53, or ER proteins, they
are most likely Golgi derived. These results are thus con-
sistent with genetic data from yeast suggesting that
coatomer is involved in regulating membrane transport
from the Golgi complex to the ER. 
Interestingly, injected anti-EAGE neither leads to accu-
mulation of KDEL receptor in the Golgi complex in normal
cells, nor inhibit BFA-dependent relocation of KDEL re-
ceptor to the IC. It has been reported that at steady state
most of the KDEL receptor is localized to the cis-Golgi
(Lewis and Pelham, 1992; Tang et al., 1993). Since the
BFA-induced relocation of Golgi resident membrane pro-
teins to the ER/IC aggregates is inhibited by injected anti-
EAGE, direct retrograde transport of KDEL receptor to
the IC and BFA-induced transfer of Golgi resident pro-
teins to the ER must follow independent routes. The sim-
plest explanation for this finding is that the bulk of the
KDEL receptor cycles at, or between, the interfaces be-
tween the ER (IC) and the Golgi complex (cis-Golgi net-
work; see also Griffiths et al., 1994; Tang et al., 1995), and
that in this cycle, recycling is independent of COPI that is
recognized by anti-EAGE. Anti-EAGE will only affect re-
location to the ER of resident Golgi proteins. This obser-
vation in fact further supports a role for COPI in antero-
grade early secretory membrane traffic. If recycling of an
essential factor were inhibited by injected anti-EAGE,
then KDEL receptor retrieval should also be affected. It is
possible that in normal cells anti-EAGE affects antero-
grade COPI-dependent membrane traffic more effectively,
because it binds to this form of coatomer with higher affin-
ity. This possibility is fully consistent with the hypothesis
that coatomer is involved in more than one transport step,
and that for each distinct transport step, coatomer has dif-
ferent conformation or composition (i.e., different post-
translational modification of subunits, different subunit
Figure 10. Anti-EAGE increases binding of b-COP to mem-
branes in vitro. 14 mg of membranes enriched in IC and Golgi were
incubated for 10 min at 378C with 160 mg rat liver cytosol in a re-
action mixture containing either no additions (cytosol), 25 mM
GTPgS (GTPgS), 10 mg of anti-EAGE (EAGE), 10 mg Fab-frag-
ments of anti-EAGE (EAGE-Fabs), 10 mg anti-110-12 (110-12),
anti-EAGE preincubated with the EAGE peptide (EAGE 1
Peptide), or 30 mg EAGE peptide (Peptide). To block anti-EAGE
antibodies 10 mg IgG was incubated with 30 mg EAGE peptide in
PBS for 30 min on ice immediately before addition to the reac-
tion. Membrane bound b-COP was detected by immunoblotting
with M3A5 as described in Materials and Methods. Shown is a
quantitation of the immunoblots from two duplicate experiments
(top) and a corresponding autoradiogram (bottom). Error bars
represent the standard mean error.Scheel et al. Anti-EAGE Inhibits BFA-induced Fusion of Golgi with ER Membranes 331
isoforms, etc.; see Whitney et al., 1995; Scheff et al., 1996;
Fiedler et al., 1996; Lowe and Kreis, 1996). 
We consider it likely that anti-EAGE inhibits the bud-
ding of COPI-coated vesicles in vivo. Indeed, the number
of COPI-coated vesicles decreases significantly in micro-
injected cells (Pepperkok et al., 1993). This is in contrast
to the action of GTPgS, which also stabilizes binding of
coatomer to membranes and inhibits BFA-induced reloca-
tion of resident Golgi proteins to the ER in permeabilized
cells (Donaldson et al., 1991), but does not interfere with
the formation of COPI-coated vesicles in vitro (Melançon
et al., 1987). The nature of the accumulating tubulo-vesic-
ular clusters in BFA-treated cells injected with anti-EAGE
(many of which remain after wash-out of the drug) is un-
clear; they probably represent ER/IC membranes that ac-
cumulate when early exocytic membrane traffic is inhib-
ited by the injected antibodies and membranes pile up as
COPI-coated vesicles cannot bud (see also Pepperkok et
al., 1993). On the other hand, the aggregates (containing
resident Golgi transmembrane proteins) that form in the
BFA-treated cells injected with anti-EAGE are most likely
remnants of Golgi complex derived membranes which can-
not fuse with ER membranes as a consequence of the anti-
body induced stabilization of membrane bound coatomer.
It is tempting to speculate that components of the mem-
brane fusion machinery (e.g., v-SNAREs) are present in
these aggregates and that they are inactive while covered
by coatomer. 
Anti-EAGE inhibits reformation of Golgi stacks upon
BFA wash-out to only z50%. This indicates that two mecha-
nisms may lead to Golgi complex reassembly, one COPI
dependent and one COPI independent. This is consistent
with previous observations that not all Golgi membranes
partition into the ER upon treatment of cells with BFA
(Oprins et al., 1993; Orci et al., 1993; Hendricks et al., 1993).
In addition, two functionally different domains have been
predicted within Golgi cisternae based on two different
pathways leading to mitotic Golgi disassembly (Misteli and
Warren, 1995), and postmitotic reassembly of the Golgi
complex is regulated by two distinct fusion events depend-
ing on NSF-SNAPs-p115 and p97 (Rabouille et al., 1995;
Acharya et al., 1995). Interestingly however, although
coatomer is stably bound to membranes of the Golgi com-
plex in cells injected with anti-EAGE, and coatomer-
dependent budding of vesicles appears inhibited, BFA still
leads to the complete disappearance of stacked Golgi cis-
ternae. This result suggests that the BFA induced morpho-
logical changes of the Golgi complex cannot be attributed
alone to dissociation of COPI from Golgi membranes.
Other factors (e.g., ARF), closer in the cascade of events
to the action of BFA, may be more directly responsible for
this process.
Microinjected anti-EAGE appear to inhibit membrane
traffic from the IC to the cis-Golgi by a different mecha-
nism from that by which they inhibit BFA-induced reloca-
tion of Golgi enzymes to the ER. Only z50% of the nor-
mal transport of newly synthesized ts-O45-G to the Golgi
is inhibited by the injected antibodies (Pepperkok et al.,
1993), whereas virtually no BFA-induced transfer of Golgi
glycosidases to the ER can be measured in cells injected
with anti-EAGE. While the precise reason for this major
difference remains unclear, several possibilities can be dis-
cussed. It could for example be argued that coatomer alone
is essential for all retrograde transport, but to some extent
redundant (with COPII) for transport in the anterograde
direction. It could also be speculated that significantly
more binding sites for coatomer reside on membranes of
the Golgi complex (consistent with the predominant local-
ization of COPI to the region of the Golgi complex in nor-
mal cells) and that as a consequence inhibition of BFA-
induced Golgi to ER transport by injected anti-EAGE is
more efficient than is transport from the IC to the cis-
Golgi. Anti-EAGE may also more efficiently stabilize Golgi
membrane bound coatomer due to different conforma-
tions of coatomer subcomplexes (Lowe and Kreis, 1995,
1996; Fiedler et al., 1996) primed to produce retrograde or
anterograde directed transport vesicles. Clearly, further
experiments will be required to resolve this conundrum.
Given the recent evidence for a role of a coat immuno-
logically related to COPI in the endocytic pathway (Whit-
ney et al., 1995; Aniento et al., 1996) and the presence of
COPI subunit isoforms generated by differential phosphor-
ylation (Sheff et al., 1996), it would not be surprising if
different forms of coatomer mediated anterograde and
retrograde transport between the ER/IC and the Golgi
complex. Alternatively, COPI-coated vesicles may provide
a “paternoster” continuously recycling immature cargo, its
receptors, as well as membrane proteins of the vesicle
docking and fusion machinery between the ER/IC and the
Golgi complex. One signal for release of cargo into the
Golgi complex would then be its dissociation from chaper-
ones which are part of the sequential quality control ma-
chinery (Hammond and Helenius, 1995). Simultaneous vi-
sualization of movement of fluorescently modified cargo
and coat proteins in living cells may provide further insight
into the mechanisms of regulation of early secretory mem-
brane traffic.
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